Literature DB >> 9658146

Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

D Pyeon1, G A Splitter.   

Abstract

Interleukin-12 (IL-12), a key cytokine in immune regulation, has an important role in activating the cell-mediated immune response in infectious diseases. Recently, a dichotomy between IL-12 and IL-10 regarding progression of a variety diseases has emerged. IL-12 activates type 1 cytokine production and has an antagonistic effect on type 2 cytokines. Here, by using quantitative competitive PCR, we show that peripheral blood mononuclear cells from bovine leukemia virus-infected animals in the alymphocytotic stage of disease express an increased amount of IL-12 p40 mRNA. In contrast, IL-12 p40 mRNA expression by cells from animals with late-stage disease, termed persistent lymphocytosis, was significantly decreased compared to that by normal and alymphocytotic animals. Interestingly, IL-12 p40 mRNA was also detected in tumor-bearing animals. IL-12 p40 expression occurred only in monocytes/macrophages, not B or T lymphocytes. The present study combined with previous findings suggest that IL-12 in bovine leukemia virus-infected animals may regulate production of other cytokines such as gamma interferon and IL-10 and the progression of bovine leukosis in animals that develop more advanced disease such as a persistent lymphocytosis of B cells or B-cell lymphosarcoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658146      PMCID: PMC109906     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.

Authors:  P Klenerman; S Rowland-Jones; S McAdam; J Edwards; S Daenke; D Lalloo; B Köppe; W Rosenberg; D Boyd; A Edwards
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

2.  Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.

Authors:  D Portetelle; D Couez; C Bruck; R Kettmann; M Mammerickx; M Van der Maaten; R Brasseur; A Burny
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

3.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

Review 4.  Breaking the asymptomatic phase of HIV-1 infection.

Authors:  R H Tomar
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

Review 5.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

6.  T and B lymphocytes in persistent lymphocytic and leukemic cattle.

Authors:  H Koyama; H Nakanishi; O Kajikawa; H Yoshikawa; S Tsubaki; T Yoshikawa; H Saito
Journal:  Nihon Juigaku Zasshi       Date:  1983-08

7.  Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus.

Authors:  E N Esteban; R M Thorn; J F Ferrer
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

8.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.

Authors:  A Bertoletti; A Sette; F V Chisari; A Penna; M Levrero; M De Carli; F Fiaccadori; C Ferrari
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

9.  Bovine leukemia virus gene expression in vivo.

Authors:  L Haas; T Divers; J W Casey
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines.

Authors:  F Ameglio; M R Capobianchi; C Castilletti; P Cordiali Fei; S Fais; E Trento; F Dianzani
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more
  8 in total

1.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis.

Authors:  G H Cantor; S M Pritchard; F Dequiedt; L Willems; R Kettmann; W C Davis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.

Authors:  P Lundberg; G A Splitter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection.

Authors:  Tomohiro Okagawa; Satoru Konnai; Ryoyo Ikebuchi; Saori Suzuki; Tatsuya Shirai; Yuji Sunden; Misao Onuma; Shiro Murata; Kazuhiko Ohashi
Journal:  Vet Res       Date:  2012-05-23       Impact factor: 3.683

6.  Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade.

Authors:  Ryoyo Ikebuchi; Satoru Konnai; Tatsuya Shirai; Yuji Sunden; Shiro Murata; Misao Onuma; Kazuhiko Ohashi
Journal:  Vet Res       Date:  2011-09-26       Impact factor: 3.683

7.  Evaluation of serological response to foot-and-mouth disease vaccination in BLV infected cows.

Authors:  Rodrigo Puentes; Laureana De Brun; Agustina Algorta; Valeria Da Silva; Florencia Mansilla; Gustavo Sacco; Silvia Llambí; Alejandra V Capozzo
Journal:  BMC Vet Res       Date:  2016-06-21       Impact factor: 2.741

8.  Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection.

Authors:  Tomohiro Okagawa; Satoru Konnai; Asami Nishimori; Naoya Maekawa; Shinya Goto; Ryoyo Ikebuchi; Junko Kohara; Yasuhiko Suzuki; Shinji Yamada; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi
Journal:  Vet Res       Date:  2018-06-19       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.